Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by RADHE MOHAN and DAVID RANDALL GROSSHANS.
RADHE MOHAN
Connection Strength
6.391
DAVID RANDALL GROSSHANS
  1. Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons. Neuro Oncol. 2021 02 25; 23(2):284-294.
    View in: PubMed
    Score: 0.773
  2. Radiobiological issues in proton therapy. Acta Oncol. 2017 Nov; 56(11):1367-1373.
    View in: PubMed
    Score: 0.606
  3. Proton therapy - Present and future. Adv Drug Deliv Rev. 2017 01 15; 109:26-44.
    View in: PubMed
    Score: 0.577
  4. Interpreting the biological effects of protons as a function of physical quantity: linear energy transfer or microdosimetric lineal energy spectrum? Sci Rep. 2024 10 24; 14(1):25181.
    View in: PubMed
    Score: 0.249
  5. Mimicking large spot-scanning radiation fields for proton FLASH preclinical studies with a robotic motion platform. ArXiv. 2024 Sep 14.
    View in: PubMed
    Score: 0.247
  6. Oxygen depletion in FLASH ultra-high-dose-rate radiotherapy: A molecular dynamics simulation. Med Phys. 2020 Dec; 47(12):6551-6561.
    View in: PubMed
    Score: 0.189
  7. A simple model for calculating relative biological effectiveness of X-rays and gamma radiation in cell survival. Br J Radiol. 2020 Aug; 93(1112):20190949.
    View in: PubMed
    Score: 0.184
  8. A DNA damage multiscale model for NTCP in proton and hadron therapy. Med Phys. 2020 Apr; 47(4):2005-2012.
    View in: PubMed
    Score: 0.180
  9. Systematic microdosimetric data for protons of therapeutic energies calculated with Geant4-DNA. Phys Med Biol. 2019 11 04; 64(21):215018.
    View in: PubMed
    Score: 0.176
  10. Renormalization of radiobiological response functions by energy loss fluctuations and complexities in chromosome aberration induction: deactivation theory for proton therapy from cells to tumor control. Eur Phys J D At Mol Opt Phys. 2019 Mar; 73(3).
    View in: PubMed
    Score: 0.169
  11. Reply to Comment on 'Linear energy transfer incorporated intensity modulated proton therapy optimization'. Phys Med Biol. 2019 02 27; 64(5):058002.
    View in: PubMed
    Score: 0.168
  12. Using the Proton Energy Spectrum and Microdosimetry to Model Proton Relative Biological Effectiveness. Int J Radiat Oncol Biol Phys. 2019 06 01; 104(2):316-324.
    View in: PubMed
    Score: 0.168
  13. A mechanistic relative biological effectiveness model-based biological dose optimization for charged particle radiobiology studies. Phys Med Biol. 2018 12 21; 64(1):015008.
    View in: PubMed
    Score: 0.166
  14. Fixed- versus Variable-RBE Computations for Intensity Modulated Proton Therapy. Adv Radiat Oncol. 2019 Jan-Mar; 4(1):156-167.
    View in: PubMed
    Score: 0.166
  15. RBE Model-Based Biological Dose Optimization for Proton Radiobiology Studies. Int J Part Ther. 2018; 5(1):160-171.
    View in: PubMed
    Score: 0.163
  16. Average stopping powers for electron and photon sources for radiobiological modeling and microdosimetric applications. Phys Med Biol. 2018 03 02; 63(5):055007.
    View in: PubMed
    Score: 0.157
  17. Comparison of Monte Carlo and analytical dose computations for intensity modulated proton therapy. Phys Med Biol. 2018 02 09; 63(4):045003.
    View in: PubMed
    Score: 0.156
  18. Proceedings of the National Cancer Institute Workshop on Charged Particle Radiobiology. Int J Radiat Oncol Biol Phys. 2018 03 15; 100(4):816-831.
    View in: PubMed
    Score: 0.155
  19. Linear energy transfer incorporated intensity modulated proton therapy optimization. Phys Med Biol. 2017 12 19; 63(1):015013.
    View in: PubMed
    Score: 0.155
  20. A new formalism for modelling parameters a and ? of the linear-quadratic model of cell survival for hadron therapy. Phys Med Biol. 2017 Oct 03; 62(20):8041-8059.
    View in: PubMed
    Score: 0.153
  21. A model for relative biological effectiveness of therapeutic proton beams based on a global fit of cell survival data. Sci Rep. 2017 08 21; 7(1):8340.
    View in: PubMed
    Score: 0.151
  22. The role of image-guided intensity modulated proton therapy in glioma. Neuro Oncol. 2017 04 01; 19(suppl_2):ii30-ii37.
    View in: PubMed
    Score: 0.147
  23. Spatial mapping of the biologic effectiveness of scanned particle beams: towards biologically optimized particle therapy. Sci Rep. 2015 May 18; 5:9850.
    View in: PubMed
    Score: 0.129
  24. Dosimetric benefits of robust treatment planning for intensity modulated proton therapy for base-of-skull cancers. Pract Radiat Oncol. 2014 Nov-Dec; 4(6):384-91.
    View in: PubMed
    Score: 0.118
  25. Is there an impact of heart exposure on the incidence of radiation pneumonitis? Analysis of data from a large clinical cohort. Acta Oncol. 2014 May; 53(5):590-6.
    View in: PubMed
    Score: 0.115
  26. Incorporating variable RBE in IMPT optimization for ependymoma. J Appl Clin Med Phys. 2024 Jan; 25(1):e14207.
    View in: PubMed
    Score: 0.058
  27. Roadmap: helium ion therapy. Phys Med Biol. 2022 08 05; 67(15).
    View in: PubMed
    Score: 0.053
  28. A framework for voxel-based assessment of biological effect after proton radiotherapy in pediatric brain cancer patients using multi-modal imaging. Med Phys. 2021 Jul; 48(7):4110-4121.
    View in: PubMed
    Score: 0.049
  29. Mapping the Relative Biological Effectiveness of Proton, Helium and Carbon Ions with High-Throughput Techniques. Cancers (Basel). 2020 Dec 05; 12(12).
    View in: PubMed
    Score: 0.048
  30. Author Correction: Exploring the advantages of intensity-modulated proton therapy: experimental validation of biological effects using two different beam intensity-modulation patterns. Sci Rep. 2020 Oct 30; 10(1):19101.
    View in: PubMed
    Score: 0.047
  31. A biological effect-guided optimization approach using beam distal-edge avoidance for intensity-modulated proton therapy. Med Phys. 2020 Sep; 47(9):3816-3825.
    View in: PubMed
    Score: 0.046
  32. Exploring the advantages of intensity-modulated proton therapy: experimental validation of biological effects using two different beam intensity-modulation patterns. Sci Rep. 2020 02 21; 10(1):3199.
    View in: PubMed
    Score: 0.045
  33. Nonhomologous End Joining Is More Important Than Proton Linear Energy Transfer in Dictating Cell Death. Int J Radiat Oncol Biol Phys. 2019 12 01; 105(5):1119-1125.
    View in: PubMed
    Score: 0.043
  34. Report of the AAPM TG-256 on the relative biological effectiveness of proton beams in radiation therapy. Med Phys. 2019 Mar; 46(3):e53-e78.
    View in: PubMed
    Score: 0.042
  35. Robust optimization to reduce the impact of biological effect variation from physical uncertainties in intensity-modulated proton therapy. Phys Med Biol. 2019 01 08; 64(2):025004.
    View in: PubMed
    Score: 0.042
  36. National Cancer Institute Workshop on Proton Therapy for Children: Considerations Regarding Brainstem Injury. Int J Radiat Oncol Biol Phys. 2018 05 01; 101(1):152-168.
    View in: PubMed
    Score: 0.040
  37. Erratum: "Monte Carlo simulations of 3 He ion physical characteristics in a water phantom and evaluation of radiobiological effectiveness" [Med. Phys. 43 (2), page range 761-776(2016)]. Med Phys. 2018 Mar; 45(3):1301.
    View in: PubMed
    Score: 0.039
  38. Erratum: "Analysis of the track- and dose-averaged LET and LET spectra in proton therapy using the geant4 Monte Carlo code" [Med. Phys. 42 (11), page range 6234-6247(2015)]. Med Phys. 2018 Mar; 45(3):1302.
    View in: PubMed
    Score: 0.039
  39. Optimization of Monte Carlo particle transport parameters and validation of a novel high throughput experimental setup to measure the biological effects of particle beams. Med Phys. 2017 Nov; 44(11):6061-6073.
    View in: PubMed
    Score: 0.038
  40. The Potential of Heavy-Ion Therapy to Improve Outcomes for Locally Advanced Non-Small Cell Lung Cancer. Front Oncol. 2017; 7:201.
    View in: PubMed
    Score: 0.038
  41. Clinical evidence of variable proton biological effectiveness in pediatric patients treated for ependymoma. Radiother Oncol. 2016 12; 121(3):395-401.
    View in: PubMed
    Score: 0.036
  42. Monte Carlo simulations of ?He ion physical characteristics in a water phantom and evaluation of radiobiological effectiveness. Med Phys. 2016 Feb; 43(2):761-76.
    View in: PubMed
    Score: 0.034
  43. Analysis of the track- and dose-averaged LET and LET spectra in proton therapy using the geant4 Monte Carlo code. Med Phys. 2015 Nov; 42(11):6234-47.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.